Sarepta Therapeutics

YTD

ALL

Trade Sarepta Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SRPT

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

CEO

Douglas S. Ingram

CEODouglas S. Ingram

Employees

1,372

Employees1,372

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

1980

Founded1980

Employees

1,372

Employees1,372

SRPT Key Statistics

Market cap

1.85B

Market cap1.85B

Price-Earnings ratio

-23.94

Price-Earnings ratio-23.94

Dividend yield

—

Dividend yield—

Average volume

10.07M

Average volume10.07M

High today

$19.61

High today$19.61

Low today

$17.95

Low today$17.95

Open price

$18.08

Open price$18.08

Volume

6.41M

Volume6.41M

52 Week high

$138.81

52 Week high$138.81

52 Week low

$10.42

52 Week low$10.42

SRPT News

Simply Wall St 8h

How Sarepta’s Shift to the S&P 600 Could Reshape Its Investment Narrative

Sarepta Therapeutics was recently removed from multiple S&P 400 indexes and added to the S&P 600 and S&P 600 Health Care indexes, reflecting a shift in its clas...

TipRanks 2d

Sarepta Therapeutics Restructures Amid ELEVIDYS Challenges

Sarepta Therapeutics Inc. ((SRPT)) has held its Q2 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage o...

TipRanks 5d

Sarepta Therapeutics Completes Convertible Notes Exchange

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Analyst ratings

61%

of 28 ratings

Buy

21.4%

Hold

60.7%

Sell

17.9%

People also own

Based on the portfolios of people who own SRPT. This list is generated using Robinhood data, and it’s not a recommendation.